Cargando…
Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA
Endocrine therapies such as tamoxifen and aromatase inhibitors are the standard treatment options for estrogen receptor-positive breast cancer patients. However, resistance to these agents has become a major clinical obstacle. Potential mechanisms of resistance to endocrine therapies have been ident...
Autores principales: | Hayes, Erin L, Lewis-Wambi, Joan S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362832/ https://www.ncbi.nlm.nih.gov/pubmed/25849966 http://dx.doi.org/10.1186/s13058-015-0542-y |
Ejemplares similares
-
Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer
por: Jan, Rifat, et al.
Publicado: (2012) -
Retraction Note: Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer
por: Jan, Rifat, et al.
Publicado: (2023) -
Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer
por: Provance, Olivia K., et al.
Publicado: (2019) -
Long Noncoding RNAs Involved in the Endocrine Therapy Resistance of Breast Cancer
por: Takeiwa, Toshihiko, et al.
Publicado: (2020) -
The Role of Long Noncoding RNAs in Antiestrogen Resistance in Breast Cancer: An Overview and Update
por: Huang, Lan, et al.
Publicado: (2020)